All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @wendyjayne_with_a_y on TikTok · 185s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @wendyjayne_with_a_y's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00This is my two-week update on my peptide journey currently taking
  2. 0:06GHK-Cu my lovely little copper peptide
  3. 0:10BPC-157 and TV 500 in the previous video. I did explain what they're all for
  4. 0:17But so far I can honestly say I've promised I'd be honest is I've not noticed that much difference
  5. 0:25I'm collagen and elastin that's why I'm taking the copper peptide. I really think though
  6. 0:31It's too soon to tell I didn't expect miracles and according to chat GPT and all where the research is going to take about
  7. 0:39Six to eight weeks before I notice any difference
  8. 0:43So nothing there in regards to the skin still got quite a bit of wrinkles around my neck and everything
  9. 0:49So I've got wrinkly arms nothing to change there
  10. 0:52Supposed to stimulate hair bros as well
  11. 0:54But obviously that would be like miraculous because it's only been two weeks
  12. 0:59So again, I'm still gonna trust the process and see how it goes in four weeks six weeks eight weeks, etc
  13. 1:06The body compound 157 the one that's supposed to promote healing and repair
  14. 1:11I told you I had a really bad tennis elbow for weeks and weeks and weeks now. It hasn't gone
  15. 1:18But it isn't as painful now whether that's down to this lovely peptide
  16. 1:24Or that's just how my body would have healed itself anyway. I can't really tell and
  17. 1:31Likewise with a TB-500 supposed to reduce
  18. 1:35Information and improve flexibility and mobility. Well, I did have
  19. 1:41On the very day I started these peptides
  20. 1:43I went to the gym and worked extra hard and I pulled a muscle in my thigh and I was limping around for
  21. 1:51a few days, but that went pretty quickly so but again, I can't pinpoint it particularly to
  22. 1:59either of those peptides
  23. 2:02The one thing I will say is I do know that BPC
  24. 2:07157 is also supposed to have really good gut healing properties and
  25. 2:13All I'm going to say is because I'm a nice girl. I'm a lady is that on the charts
  26. 2:19I would have been every single day since I've taken this
  27. 2:24And I'm before that's all I'm gonna say and number four is where you want to be and for those of you
  28. 2:30I've got a clue what I'm all about go on the internet look up the Bristol chart
  29. 2:36Now that's unusual for me, but it's a wonderfully therapeutic
  30. 2:41Side effect or a result of taking this I hope it is an unlimited rain
  31. 2:49Anyway, I'll update your gay in
  32. 2:53Say another month when hopefully might see some hair growth
  33. 2:56Not 10 years off myself and I'll be
  34. 3:00Swinging on the monkey bars like a five-year-old. Well, we're living hope

@wendyjayne_with_a_y's peptide glow claims lack evidence

wendyjayne_with_a_y

TikTok creator

138.8K viewsWatch on TikTok →

Quick answer

The creator is self-administering three separate peptides simultaneously, GHK-Cu, BPC-157, and TB-500, with no mention of medical supervision, baseline labs, or dosing protocol guidance from a clinician. At two weeks, she reports no skin changes and equivocal musculoskeletal results, with one subjective gut improvement that cannot be attributed to any single compound given the stacked protocol. This case illustrates why concurrent multi-peptide use without oversight makes it nearly impossible to assess efficacy or identify the source of any adverse effects.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion
Start provider reviewBrowse video library

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 8 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @wendyjayne_with_a_y's peptide glow claims lack evidence, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

ReviewBPC-157 evidence2025

Multifunctionality and Possible Medical Application of the BPC 157 Peptide

Used to frame BPC-157 as an investigational peptide with mixed preclinical and limited human evidence.

PubMed

ReviewBPC-157 evidence2019

Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing

Supports cautious tissue-repair context without presenting BPC-157 as an approved therapy.

PubMed

ReviewThymosin beta-4 evidence2007

beta-Thymosins

Background source for thymosin biology and tissue-repair mechanisms.

PubMed

ReviewThymosin beta-4 evidence2018

Thymosin beta 4 and the eye: the journey from bench to bedside

Shows how thymosin beta-4 evidence differs by route, tissue, and clinical application.

PubMed

Provider decision path

Use local research to choose a safer review path

Direct answer

@wendyjayne_with_a_y's peptide glow claims lack evidence is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Start the provider review

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Helpful context before the funnel

Review method

See how FormBlends checks viral health claims.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@wendyjayne_with_a_y's peptide glow claims lack evidence" from wendyjayne_with_a_y. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator is self-administering three separate peptides simultaneously, GHK-Cu, BPC-157, and TB-500, with no mention of medical supervision, baseline labs, or dosing protocol guidance from a clinician.

The reason this review is not generic is the source wording and the canonical claim label "peptides early days but one promising early result peptide glow b." In this clip, the useful excerpt is: "This is my two-week update on my peptide journey currently taking GHK-Cu my lovely little copper peptide BPC-157 and TV 500 in the previous video." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Multifunctionality and Possible Medical Application of the BPC 157 Peptide (2025), Gastric pentadecapeptide BPC 157 and its role in accelerating musculoskeletal soft tissue healing (2019), and Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (2025), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

BPC-157's gut motility effects are consistently observed in rodent models, but zero peer-reviewed human RCTs confirm the Bristol Stool Chart improvement described in this video.
People who land here are usually comparing the Peptide social video fact-checks claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator is self-administering three separate peptides simultaneously, GHK-Cu, BPC-157, and TB-500, with no mention of medical supervision, baseline labs, or dosing protocol guidance from a clinician.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator is self-administering three separate peptides simultaneously, GHK-Cu, BPC-157, and TB-500, with no mention of medical supervision, baseline labs, or dosing protocol guidance from a clinician. At two weeks, she reports no skin changes and equivocal musculoskeletal results, with one subjective gut improvement that cannot be attributed to any single compound given the stacked protocol. This case illustrates why concurrent multi-peptide use without oversight makes it nearly impossible to assess efficacy or identify the source of any adverse effects.
  • GHK-Cu has the strongest preclinical evidence of the three peptides for collagen synthesis, but most human data supports topical application, not systemic injection (Pickart et al., 2015, Journal of Aging Research).
  • BPC-157's gut motility effects are consistently observed in rodent models, but zero peer-reviewed human RCTs confirm the Bristol Stool Chart improvement described in this video.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • GHK-Cu has the strongest preclinical evidence of the three peptides for collagen synthesis, but most human data supports topical application, not systemic injection (Pickart et al., 2015, Journal of Aging Research).
  • BPC-157's gut motility effects are consistently observed in rodent models, but zero peer-reviewed human RCTs confirm the Bristol Stool Chart improvement described in this video.
  • TB-500 has almost no human clinical trial data for the recovery and anti-inflammatory uses promoted in biohacking communities, making claims about it largely speculative.
  • Self-attributing outcomes when taking three peptides simultaneously is not possible. You cannot identify which compound caused an effect, or whether any of them did.
  • A 2023 JAMA Internal Medicine analysis flagged significant purity and dosing accuracy problems in compounded peptides sourced outside licensed medical providers, a real safety concern for self-sourced protocols.
  • Sourcing clinical timelines from ChatGPT rather than a prescribing clinician is a meaningful risk when you are injecting unregulated compounds into your body.
  • The creator's honest uncertainty about causation is more scientifically sound than most peptide content on TikTok, but honesty about not knowing is not the same as a protocol being safe or evidence-based.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @wendyjayne_with_a_y actually say?

Refreshingly, she said almost nothing went wrong with her two-week update, and she was upfront about it. She reported no visible skin changes, no hair growth, and admitted her tennis elbow improvement and faster muscle recovery could just as easily be natural healing. The one thing she did flag as a possible win was gut motility, saying BPC-157 gave her consistent, well-formed bowel movements every day, which she described as unusual for her. She sourced her timeline expectations from ChatGPT, not a clinician, expecting six to eight weeks before noticing skin changes. Overall this is one of the more honest peptide videos you will find on TikTok, which is a low bar, but credit where it is due.

Does the science back this up?

Partly, but the picture is messier than most peptide content admits. GHK-Cu has real preclinical data behind it. BPC-157's gut benefits are mostly rodent data. TB-500 barely has human trials at all.

GHK-Cu (copper tripeptide-1) does have reasonably solid evidence for collagen stimulation at the cellular level. Pickart et al. (2015, Journal of Aging Research) showed it upregulates collagen and elastin synthesis in fibroblast cultures, and there is some human topical data. The six to eight week timeline for skin remodeling is plausible, though that evidence is largely for topical application, not systemic injection.

BPC-157's gut claim is where it gets interesting. Sikiric et al. (2016, Current Pharmaceutical Design) documented consistent pro-motility and mucosal healing effects in rodent models of inflammatory bowel conditions. Whether that translates directly to improved Bristol stool scores in healthy humans is genuinely unknown. There are no peer-reviewed human trials for oral or injected BPC-157 in gut health specifically.

TB-500 (Thymosin Beta-4) has the thinnest human evidence of the three. Most data is from animal models of cardiac and musculoskeletal repair. No randomized controlled trials in humans for athletic recovery or inflammation exist in the published literature.

What did they get wrong (or right)?

She got the honest uncertainty right, but she got her research source wrong. Using ChatGPT to set clinical timelines is a problem worth naming directly.

  • Right: Acknowledging she cannot attribute her elbow or muscle improvements to the peptides over natural healing. That is exactly the correct epistemic position, and most TikTok biohackers do not take it.
  • Right: The six to eight week estimate for collagen and skin remodeling is actually consistent with dermatological literature on skin turnover cycles, even if she got it from a chatbot.
  • Wrong: Calling TB-500 "TV 500" and not correcting it reflects the broader issue that she is self-administering compounds she is still learning to name. That is not a minor point when these are injectable peptides.
  • Wrong: The gut improvement anecdote, while plausible, is being treated as near-confirmation of BPC-157 working. Two weeks of consistent bowel movements could be placebo effect, dietary changes, or the simple act of paying more attention to your body once you start a new protocol.

What should you actually know?

These three peptides occupy very different places on the evidence spectrum, and that distinction matters before you inject anything.

GHK-Cu is the most studied of the three and has the strongest case for skin-related benefits, though most robust evidence is topical, not systemic. BPC-157 has a genuinely interesting gut and soft-tissue healing signal in animal research, but the leap to human clinical use is not yet supported by controlled trials. TB-500 is largely theoretical for the use cases being discussed in biohacking communities. None of these peptides are FDA-approved for the purposes described in this video.

The Bristol Stool Chart anecdote is worth taking seriously as a self-reported observation, but it is not evidence BPC-157 fixed anything. Gut motility is sensitive to stress, sleep, hydration, and diet, all of which change when someone starts a new health protocol.

Self-sourcing peptides without medical supervision carries real risks: incorrect dosing, contamination in unregulated supply chains, and no safety monitoring. That is not a hypothetical concern. A 2023 analysis published in JAMA Internal Medicine found significant quality and purity issues in compounded peptide products obtained outside of licensed telehealth providers.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

wendyjayne_with_a_y · TikTok creator

138.8K views on this video

Early days but one promising early result 🙏 #peptide#glow#biohacking#glowup#agingwell @wendyjayne_with_a_y

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about ghk-cu has the strongest preclinical evidence of the three peptides?

GHK-Cu has the strongest preclinical evidence of the three peptides for collagen synthesis, but most human data supports topical application, not systemic injection (Pickart et al., 2015, Journal of Aging Research).

What does the video say about bpc-157's gut motility effects?

BPC-157's gut motility effects are consistently observed in rodent models, but zero peer-reviewed human RCTs confirm the Bristol Stool Chart improvement described in this video.

What does the video say about tb-500 has almost no human clinical trial data for the?

TB-500 has almost no human clinical trial data for the recovery and anti-inflammatory uses promoted in biohacking communities, making claims about it largely speculative.

What does the video say about self-attributing outcomes?

Self-attributing outcomes when taking three peptides simultaneously is not possible. You cannot identify which compound caused an effect, or whether any of them did.

What does the video say about a 2023 jama internal medicine analysis flagged significant purity?

A 2023 JAMA Internal Medicine analysis flagged significant purity and dosing accuracy problems in compounded peptides sourced outside licensed medical providers, a real safety concern for self-sourced protocols.

What does the video say about sourcing clinical timelines from chatgpt rather than a prescribing clinician?

Sourcing clinical timelines from ChatGPT rather than a prescribing clinician is a meaningful risk when you are injecting unregulated compounds into your body.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by wendyjayne_with_a_y, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.